AOD9604 Peptide for Fat Loss: Mechanism, Benefits & Risks Explained AOD9604 Wikipedia The anti obesity drug AOD 9604 is banned by WADA and ASADA in a blow to Essendon's defence FDA Peptide Reclassification 2026: What It Means for Providers Detection and in vitro metabolism of AOD9604 Cox 2015 Drug Testing and Analysis Wiley Online Library The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York